Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412

por Nowakowski, Grzegorz S., Hong, Fangxin, Scott, David W., Macon, William R., King, Rebecca L., Habermann, Thomas M., Wagner-Johnston, Nina, Casulo, Carla, Wade, James L., Nagargoje, Gauri G., Reynolds, C. M., Cohen, Jonathon B., Khan, Nadia, Amengual, Jennifer E., Richards, Kristy L., Little, R. F., Leonard, John P., Friedberg, Jonathan W., Kostakoglu, Lale, Kahl, Brad S., Witzig, Thomas E.
Publicado 2021

Phase III Study to Evaluate Efficacy and Safety of Andecaliximab With mFOLFOX6 as First-Line Treatment in Patients With Advanced Gastric or GEJ Adenocarcinoma (GAMMA-1)

por Shah, Manish A., Bodoky, Gyorgy, Starodub, Alexander, Cunningham, David, Yip, Desmond, Wainberg, Zev A., Bendell, Johanna, Thai, Dung, He, Joyce, Bhargava, Pankaj, Ajani, Jaffer A.
Publicado 2021

Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion–Positive Non–Small-Cell Lung Cancer

por Dziadziuszko, Rafal, Krebs, Matthew G., De Braud, Filippo, Siena, Salvatore, Drilon, Alexander, Doebele, Robert C., Patel, Manish R., Cho, Byoung Chul, Liu, Stephen V., Ahn, Myung-Ju, Chiu, Chao-Hua, Farago, Anna F., Lin, Chia-Chi, Karapetis, Christos S., Li, Yu-Chung, Day, Bann-mo, Chen, David, Wilson, Timothy R., Barlesi, Fabrice
Publicado 2021

ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma

por Nowakowski, Grzegorz S., Chiappella, Annalisa, Gascoyne, Randy D., Scott, David W., Zhang, Qingyuan, Jurczak, Wojciech, Özcan, Muhit, Hong, Xiaonan, Zhu, Jun, Jin, Jie, Belada, David, Bergua, Juan Miguel, Piazza, Francesco, Mócikova, Heidi, Molinari, Anna Lia, Yoon, Dok Hyun, Cavallo, Federica, Tani, Monica, Yamamoto, Kazuhito, Izutsu, Koji, Kato, Koji, Czuczman, Myron, Hersey, Sarah, Kilcoyne, Adrian, Russo, Jacqueline, Hudak, Krista, Zhang, Jingshan, Wade, Steve, Witzig, Thomas E., Vitolo, Umberto
Publicado 2021

Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma

por McDermott, David F., Lee, Jae-Lyun, Bjarnason, Georg A., Larkin, James M. G., Gafanov, Rustem A., Kochenderfer, Mark D., Jensen, Niels Viggo, Donskov, Frede, Malik, Jahangeer, Poprach, Alexandr, Tykodi, Scott S., Alonso-Gordoa, Teresa, Cho, Daniel C., Geertsen, Poul F., Climent Duran, Miguel Angel, DiSimone, Christopher, Silverman, Rachel Kloss, Perini, Rodolfo F., Schloss, Charles, Atkins, Michael B.
Publicado 2021

Phase I Study of Elacestrant (RAD1901), a Novel Selective Estrogen Receptor Degrader, in ER-Positive, HER2-Negative Advanced Breast Cancer

por Bardia, Aditya, Kaklamani, Virginia, Wilks, Sharon, Weise, Amy, Richards, Donald, Harb, Wael, Osborne, Cynthia, Wesolowski, Robert, Karuturi, Meghan, Conkling, Paul, Bagley, Rebecca G., Wang, Yamei, Conlan, Maureen G., Kabos, Peter
Publicado 2021

Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes

por Bersanelli, Matteo, Travaglino, Erica, Meggendorfer, Manja, Matteuzzi, Tommaso, Sala, Claudia, Mosca, Ettore, Chiereghin, Chiara, Di Nanni, Noemi, Gnocchi, Matteo, Zampini, Matteo, Rossi, Marianna, Maggioni, Giulia, Termanini, Alberto, Angelucci, Emanuele, Bernardi, Massimo, Borin, Lorenza, Bruno, Benedetto, Bonifazi, Francesca, Santini, Valeria, Bacigalupo, Andrea, Voso, Maria Teresa, Oliva, Esther, Riva, Marta, Ubezio, Marta, Morabito, Lucio, Campagna, Alessia, Saitta, Claudia, Savevski, Victor, Giampieri, Enrico, Remondini, Daniel, Passamonti, Francesco, Ciceri, Fabio, Bolli, Niccolò, Rambaldi, Alessandro, Kern, Wolfgang, Kordasti, Shahram, Sole, Francesc, Palomo, Laura, Sanz, Guillermo, Santoro, Armando, Platzbecker, Uwe, Fenaux, Pierre, Milanesi, Luciano, Haferlach, Torsten, Castellani, Gastone, Della Porta, Matteo G.
Publicado 2021

Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Rando...

por Kanemitsu, Yukihide, Shitara, Kohei, Mizusawa, Junki, Hamaguchi, Tetsuya, Shida, Dai, Komori, Koji, Ikeda, Satoshi, Ojima, Hitoshi, Ike, Hideyuki, Shiomi, Akio, Watanabe, Jun, Takii, Yasumasa, Yamaguchi, Takashi, Katsumata, Kenji, Ito, Masaaki, Okuda, Junji, Hyakudomi, Ryoji, Shimada, Yasuhiro, Katayama, Hiroshi, Fukuda, Haruhiko
Publicado 2021

Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 1...

por Moehler, Markus, Dvorkin, Mikhail, Boku, Narikazu, Özgüroğlu, Mustafa, Ryu, Min-Hee, Muntean, Alina S., Lonardi, Sara, Nechaeva, Marina, Bragagnoli, Arinilda C., Coşkun, Hasan S., Cubillo Gracian, Antonio, Takano, Toshimi, Wong, Rachel, Safran, Howard, Vaccaro, Gina M., Wainberg, Zev A., Silver, Matthew R., Xiong, Huiling, Hong, Janet, Taieb, Julien, Bang, Yung-Jue
Publicado 2021

Randomized Phase III Study of FOLFOX Alone or With Pegilodecakin as Second-Line Therapy in Patients With Metastatic Pancreatic Cancer That Progressed After Gemcitabine (SEQUOIA)

por Hecht, J. Randolph, Lonardi, Sara, Bendell, Johanna, Sim, Hao-Wen, Macarulla, Teresa, Lopez, Charles D., Van Cutsem, Eric, Muñoz Martin, Andres J., Park, Joon Oh, Greil, Richard, Wang, Hong, Hozak, Rebecca R., Gueorguieva, Ivelina, Lin, Yong, Rao, Sujata, Ryoo, Baek-Yeol
Publicado 2021

Persistent Disparity: Socioeconomic Deprivation and Cancer Outcomes in Patients Treated in Clinical Trials

por Unger, Joseph M., Moseley, Anna B., Cheung, Christabel K., Osarogiagbon, Raymond U., Symington, Banu, Ramsey, Scott D., Hershman, Dawn L.
Publicado 2021

Acute and chronic infection: Is there a gold standard for management of the wound and bone defect?

por Giannoudis, Peter V., Tosounidis, Theodoros H.
Publicado 2020

Hardware considerations in infection and nonunion management: When and how to revise the fixation

por Hoit, Graeme, Bonyun, Marissa, Nauth, Aaron
Publicado 2020

Antibiotic utilization in open fractures

por Atwan, Yousif, Miclau, Theodore, Schemitsch, Emil H., Teague, David
Publicado 2020

Open fractures with soft-tissue loss: Coverage options and timing of surgery

por Coles, Chad P.
Publicado 2020

Hip fracture systems—European experience

por Chesser, Tim J.S., Inman, Dominic, Johansen, Antony, Belluati, Alberto, Pari, Carlotta, Contini, Achille, Voeten, Stijn.C., Hegeman, Johannes H., Ponsen, Kornelis J., Montero-Fernández, Nuria, Delgado-Martínez, Alberto, Chana-Rodríguez, Francisco
Publicado 2020

Hip fracture care and national systems: The United States and Canada

por Swenning, Todd, Leighton, Jennifer, Nentwig, Michelle, Dart, Bradley
Publicado 2020

Hip fracture care—Latin America

por Rojas, Luis Gerardo Padilla, Hernández, Sergio Quintero, Ávila, José María Jiménez, Cervantes, Roberto Enrique López, Enghelmayer, Rafael Amadei, Pesciallo, Cesar, Garabano, German, Mackechnie, Madeline C., Quintero, José Eduardo, Kojima, Kodi E.
Publicado 2020

Prevalence of posttraumatic stress disorder in acute trauma patients

por Joseph, Noah M., Benedick, Alex, Flanagan, Christopher D., Breslin, Mary A., Simpson, Megen, Ragone, Christina, Kalina, Mark, Hendrickson, Sarah B., Vallier, Heather A.
Publicado 2020

User Experience With Low-Cost Virtual Reality Cancer Surgery Simulation in an African Setting

por Bing, Eric G., Brown, Megan L., Cuevas, Anthony, Sullivan, Richard, Parham, Groesbeck P.
Publicado 2021